IEQ Capital’s Crescent Biopharma CBIO Stock Holding History

IEQ Capital’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-384	Closed	-$8.06K	–	1896
2025 Q1	$8.06K	Hold	384	–	–	﹤0.01%	1603
2024 Q4	$9.55K	Hold	384	–	–	﹤0.01%	1324
2024 Q3	$6.48K	Hold	384	–	–	﹤0.01%	1155
2024 Q2	$10.8K	Hold	384	–	–	﹤0.01%	1000
2024 Q1	$115K	Hold	384	–	–	﹤0.01%	921
2023 Q4	$90.5K	Hold	384	–	–	﹤0.01%	885
2023 Q3	$57.5K	Hold	384	–	–	﹤0.01%	909
2023 Q2	$66.8K	Hold	384	–	–	﹤0.01%	873
2023 Q1	$48.3K	Hold	384	–	–	﹤0.01%	877
2022 Q4	$116K	Hold	384	–	–	﹤0.01%	764
2022 Q3	$21K	Hold	384	–	–	﹤0.01%	835
2022 Q2	$23K	Hold	384	–	–	﹤0.01%	792
2022 Q1	$44K	Hold	384	–	–	﹤0.01%	803
2021 Q4	$55K	Hold	384	–	–	﹤0.01%	716
2021 Q3	$84K	Hold	384	–	–	﹤0.01%	682
2021 Q2	$89K	Hold	384	–	–	﹤0.01%	602
2021 Q1	$115K	Buy	+384	New	+$138K	﹤0.01%	472

Other funds holding CBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return